Tumor lysis syndrome early after treatment with bortezomib for multiple myeloma

被引：13

作者：

Kenealy, Melita K. ^{[1
]}

Prince, H. Miles ^{[1
]}

Honemann, Dirk ^{[1
]}

机构：

[1] Peter MacCallum Canc Ctr, Dept Haematol & Med Oncol, Melbourne, Vic 3001, Australia

来源：

PHARMACOTHERAPY | 2006年 / 26卷 / 08期

关键词：

bortezomib; tumor lysis syndrome; TLS; multiple myeloma;

D O I：

10.1592/phco.26.8.1205

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1205 / 1206

页数：2

共 7 条

[1]

ATHANASIOS B, 1999, BRIT J HAEMATOL, V105, P938

[2]

Cany L, 2002, J CLIN ONCOL, V20, P2212

[3] Tumor lysis syndrome in a multiple myeloma treated with thalidomide [J].

Fuente, N ;

Mañe, JM ;

Barcelo, R ;

Muñoz, A ;

Perez-Hoyos, T ;

Lopez-Vivanco, G .

ANNALS OF ONCOLOGY, 2004, 15 (03) :537-537

[4] Tumor lysis syndrome after bortezomib therapy for plasma cell leukemia [J].

Jaskiewicz, AD ;

Herrington, JD ;

Wong, L .

PHARMACOTHERAPY, 2005, 25 (12) :1820-1825

[5]

Mehta J, 2003, BLOOD, V102, p386B

[6] Bortezomib or high-dose dexamethasone for relapsed multiple myeloma [J].

Richardson, PG ;

Sonneveld, P ;

Schuster, MW ;

Irwin, D ;

Stadtmauer, EA ;

Facon, T ;

Harousseau, JL ;

Ben-Yehuda, D ;

Lonial, S ;

Goldschmidt, H ;

Reece, D ;

San-Miguel, JF ;

Bladé, J ;

Boccadoro, M ;

Cavenagh, J ;

Dalton, WS ;

Boral, AL ;

Esseltine, DL ;

Porter, JB ;

Schenkein, D ;

Anderson, KC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24) :2487-2498

[7] Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration [J].

Terpos, E ;

Politou, M ;

Rahemtulla, A .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (10) :623-625

← 1 →